A specific probiotic intervention to improve quality of life (QoL) in allergic rhinitis (PIQAR-study): a randomised, double-blind, placebo-controlled trial

Griffith University0 个研究点目标入组 160 人开始时间: 2019年9月26日最近更新: 2022年11月28日

适应症

试验速览

暂无简介。

•Be Male or female;
•Be aged between 18-65 years;
•Have more than 2 years history of moderate to severe persistent allergic rhinitis;
•Have moderate to severe allergic rhinitis as rated by the Allergic Rhinitis and its Impact
•on Asthma (ARIA) criteria
•Have a positive radio-allergosorbent test (RAST) to Bermuda (couch) grass.

•Have non-allergic rhinitis
•Have a negative RAST to Bermuda grass
•Report consumption of probiotics or prebiotics in the previous 12 weeks;
•Report treatment with systemic corticosteroids in the previous 6 months;
•Have a history of respiratory diseases such as nasal polyposis and COPD ;
•Have a current respiratory viral infectious disease (common cold);
•Report current pregnancy or attempting to become pregnant;
•Report use of medications which effect salivary flow and components such as systemic
•corticosteroids, diuretics and antidepressants;
•Allergic, sensitive or intolerant to (one of) the ingredients of the study product.

发起方